PPT Slide

• Continue to advance research

• Developed new scientific methods to streamline feasibility process

  • Expedited carrier selection using PYY3-36 as a case study
  • Demonstrated that PYY3-36 can be delivered orally at pharmacologically relevant levels in rodents
  • Proceed to solid dosage form development

Summary

Case Study: PYY3-36

Previous slide

Next slide

Back to first slide

View graphic version